AFC-158CL

antibody from Creative Biolabs

Targeting: CLDN18 SFTPJ

No application information provided.

Antibody Data

Product number

AFC-158CL

Provider

Creative Biolabs

Product name

Afuco? Anti-Human CLDN18 ADCC Recombinant Antibody (claudiximab), ADCC Enhanced

Antibody type

Monoclonal

Description

Anti-CLDN18 ADCC Enhanced Antibody (claudiximab) is an ADCC enhanced antibody produced by our Afuco? platform. Claudiximab is a monoclonal antibody specific for gastric and gastroesophageal adenocarcinomas. Preclinically, claudiximab was shown to inhibit tumor growth and to kill cancer cells by indirect (complement-dependent cytoxicity, antibody-dependent cellular cytotoxicity) and direct mechanisms (antiproliferative and proapoptotic effects).

Reactivity

Human

Storage

Store at -20¡ãC. Avoid multiple freeze/thaw cycles.